START New Jersey operates in partnership with Astera Cancer Care, bringing early-phase oncology research directly to patients across the Northeast US. Led by Dr. Bruno Fang, the site combines Astera’s community-based care model with START’s global research excellence to accelerate access to innovative cancer therapies.

The facility includes a fully dedicated infusion area, on-site exam rooms, a state-of-the-art sterile compounding pharmacy, and a pharmacokinetic (PK) laboratory designed for precision and compliance. START New Jersey also offers private monitoring spaces and a dedicated conference room for sponsor collaboration in addition to on-site CT and MRI imaging and in-house laboratory services —ensuring a seamless clinical experience from screening to treatment.

Together, these capabilities position START New Jersey as a key hub for early-phase oncology trials, advancing START’s mission of bringing Hope Through Access to patients where they live.